Below you'll find a list of all posts that have been categorized as “Uncategorized”
The last number of years have seen a proliferation of new innovative cancer drug therapies being tested in clinical trials at CCMB, nationally, and around the world. Some of these therapies have since become available for clinical use while many more are showing promise in current trials.
Carole was diagnosed with lung cancer in 2020 shortly after retiring. The diagnosis came as a shock in no small part because Carole hadn’t smoked in over 40 years, and even then only socially. Curious about factors that cause lung cancer, Carole had her home tested for radon – a leading cause of lung cancer – and learned that the …
Septic shock, a life-threatening infection, is among the most common reasons for admission to ICUs in Manitoba and is a leading cause of death. Septic shock leads to uncontrolled inflammation and coagulation abnormalities. Apart from antibiotics and supportive care, there are few treatments available. Cancer patients are at higher risk of infections and septic shock due to immunosuppression from the underlying disease and chemotherapy.
Senior Scientist at CancerCare Manitoba Research Institute, Dr. Harvey Max Chochinov has published a new book, Dignity in Care: The Human Side of Medicine, providing insight into how the disposition and attitude of healthcare providers indelibly shape patient experience.
Shirley Mooney was first diagnosed with large B-cell lymphoma in 2008. She responded well to chemotherapy and, after six sessions, went into remission. Eleven years later, however, the cancer returned. Adding to the difficulty of her situation, Shirley experienced life-threatening complications during chemotherapy. This required a change of treatment to a stem cell transplant, which was effective. Though she was …
A new Investigator-Initiated Clinical Trial (IICT) led by Primary Investigator, Dr. Brett Houston, called the MYELO-CAN TXA trial, aims to see whether Tranexamic Acid (TXA) can help prevent bleeding in patients with certain blood cancers such as acute leukemia and myelodysplastic syndrome.
In 2014, Sandra was diagnosed with stage four lymphoma that manifested in her kidney. She never thought anything like cancer would happen to her. “You hear the word cancer and it slams into your consciousness like a bullet”, she says. Her doctors explained that the lymphoma was not terminal, so that offered Sandra some relief and a feeling like she …
The Institute has acquired a state-of-the-art magnetic resonance simulator (MR-SIM) to be installed in 2024, made possible by generous community donations. The research applications of this technology will include new patient treatment techniques and workflows.
A major donation from the Paul Albrechtsen Foundation facilitates the transformation of 20-year-old research laboratories into state-of-the-art facilities housing cutting-edge technology and leading scientists pursuing the next cancer breakthroughs.
Mark Domko stays in good shape, doesn’t smoke, doesn’t drink, and gets regular checkups with his doctor. That’s why his prostate cancer diagnosis came as such a shock in 2014. A biopsy soon confirmed it was a fast-growing cancer and Mark was scheduled for a radical prostatectomy and hormone therapy.
